Published in TB and Outbreaks Week, March 13th, 2007
"This broad patent helps to secure Vaxiion's proprietary position with regard to minicells as vaccines," said Dr. Roger A. Sabbadini, the founder and president, and a listed inventor in the patent. "This also represents a major milestone in our efforts to develop this powerful DNA and protein delivery system for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.